Lyme Disease: Gold for Scotland and Bronze for USA

Hendry G Ho-Yen D. Tick-borne human diseases. Eds. Hendry G Ho-Yen D . In Ticks. A lay guide to a human hazard. Edinburgh, Mercat Press, 1998, 1st edition, 35–55.

Shapiro ED Gerber MA. Lyme disease. Clin Infect Dis 2000; 31: 533–542.

Weber K. Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis 2001; 20: 6–13.

Cutler SJ Woodward MJ. Lyme borreliosis in the UK — ecology and risks to domestic animals and man. Rev Med Microbiol 2001; 12: 199–209.

Ho-Yen DO Davidson MM Chisholm SM Joss AWL. How prevalent is Lyme disease in Scotland? SCIEH Weekly Report 1999; 33: 214–215.

Hercogova J Brzonova I. Lyme disease in Central Europe. Curr Op Infect Dis 2001; 14: 133–137.

Nuttall P Randolph S Carey D Craine N Livesley A Gern L. The ecology of Lyme borreliosis in the UK. Eds. Axford JS Rees DHE . In: Lyme Borreliosis, New York, Plenum Press 1994, 125–129.

Hubbard MJ Baker AS Cann KJ. Distribution of Borrelia burgdorferi s.l. spirochaete DNA in British ticks (Argasidae and Ixodidae) since the 19^th century, assessed by PCR. Med Vet Entomol 1998; 12: 89–97.

Ling CL Joss AWL Davidson MM Ho-Yen DO. Identification of different Borrelia burgdorferi genomic groups from Scottish ticks. J Clin Pathol: Mol Pathol 2000; 53: 94–98.

Livesley MA Carey D Gern L Nuttall PA. Problems of isolating Borrelia burgdorferi from ticks collected in United Kingdom foci of Lyme disease. Med Vet Entomol 1994; 8: 172–178.

Davidson MM Evans R Ling CL Wiseman AD Joss AWL Ho-Yen DO. Isolation of Borrelia burgdorferi from ticks in the Highlands of Scotland. J Med Microbiol 1999; 48: 59–65.

Van Dam AP Kuiper H Vos K Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17: 708–717.

Golightly MG Benach J. Tick-borne diseases. Rev Med Microbiol 1999; 10: 1–10.

Steere AC. Lyme disease. N Engl J Med 2001; 345: 115–125.

Edlow JA. Erythema migrans. Ed. Edlow JA . In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 239–260.

Nadelman RB Wormser GP. Lyme borreliosis. Lancet 1998; 352: 557–565.

Pinto DS. Cardiac manifestations of Lyme disease. Ed. Edlow JA . In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 285–296.

Cary NRB Fox B Wright DJM Cutler SJ Shapiro LM Grace AA. Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med J 1990; 66: 134–136.

Coyle PK Schutzer SE. Neurological aspects of Lyme disease. Ed. Edlow JA . In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 261–284.

Ziska MH Donta ST Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease. Infection 1996; 23: 1–5.

Donta ST. Late and chronic Lyme disease. Ed. Edlow JA . In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 341–350.

Stanek GO Connell S Cimmino M European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741–747.

Goodlad JR Davidson MM Hollowood K Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000; 24: 1279–1285.

Cerroni L Zchling NP tz B Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457–461.

Shadick NA Phillips CB Logigian EL The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994; 121: 560–567.

Maraspin V Cimperman J Lotri-Furlan S Pleterski-Rigler D Strle F. Erythema migrans in pregnancy. Wien Klin Wochenschr 1999; 111: 933–940.

Reed KD. Laboratory testing for Lyme disease: possibilities and practicalities. J Clin Microbiol 2002; 40: 319–324.

Wormser GP Bittker S Cooper D Nowakowski J Nadelman RB Pavia C. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease. J Clin Microbiol 2000; 38: 1648–1650.

Wormser GP Bittker S Cooper D Nowakowski J Nadelman RB Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001; 184: 1070–1072.

Brettschneider S Bruckbauer H Klugbauer N Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998; 36: 2658–2665.

Dumler JS. Molecular diagnosis of Lyme disease: Review and metaanalysis. Mol Diagn 2001; 6: 1–11.

Anonymous. Recommendations for test performance and interpretation from the 2^nd national conference on serologic diagnosis of Lyme disease. MMWR: 1995; 44: 590–591.

Tugwell P Dennis DT Weinstein A Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127: 1106–1108.

Hauser U Lehnert G Lobentanzer R Wilske B. Interpretation criteria for standardized western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997; 35: 1433–1444.

Hauser U Lehnert G Wilske B. Validity of interpretation criteria for standardised western blots (Immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 1999; 37: 2241–2247.

Ryffel K P ter O Rutti B Suard A Dayer E. Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii and B. valaisiana in humans. J Clin Microbiol 1999; 37: 4086–4092.

Robertson J Guy E Andrews N A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38: 2097–2102.

Davidson MM Chisholm SM Wiseman AD Joss AWL Ho-Yen DO. Improved serodiagnosis of Lyme disease. J Clin Pathol: Mol Pathol 1996; 49: M80–M84.

Gerber MA Zemel LS Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Paediatrics 1998; 102: 905–908.

Kalish RA Kaplan RF Taylor E Jones-Woodward L Workman K Steere AC. Evaluation of study patients with Lyme disease, 10–20 year follow-up. J Infect Dis 2001; 183: 453–460.

Berglund J. Natural history and long-term consequences of Lyme disease in children. Curr Op Infect Dis 1999; 12: 265–269.

Wormser GP Nadelman RB Dattwyler RJ Practice guidelines for the treatment of Lyme disease. Clin Infect Dis, 2000; 31 (suppl 1): S1–S14.

Dovetail L Hagberg L. Successful oral doxycycline treatment of Lyme disease — associated facial palsy and meningitis. Clin Infect Dis 1999; 28: 569–574.

Reid MC Schoen RT Evans J Rosenberg JC Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128: 354–362.

Barbour AG. Expert advice and patient expectations. Laboratory testing and antibiotics for Lyme disease. J Am Med Assoc 1998; 279: 239–240.

Fix AD Strickland GT Grant J. Tick bites and Lyme disease in an endemic setting. Problematic use of serologic testing and prophylactic antibiotic therapy. J Am Med Assoc 1998; 279: 206–210.

Robertson JN Gray JS Stewart P. Tick bite and Lyme borreliosis risk at a recreational site in England. Eur J Epidemiol 2000; 16: 647–652.

Pontrelli L Dattwyler R Nachman S. Single dose doxycycline for the prevention of Lyme disease. N Engl J Med 2001; 345: 1348.

Hendry G Ho-Yen D. Know your enemy. Eds Hendry G Ho-Yen D. In Ticks. A lay guide to a human hazard. Edinburgh, Mercat Press, 1998, 1st edition, 12–24.

Guy EC Farquhar RG. Borrelia burgdorferi in urban parks. Lancet 1991; 338: 253.

Hendry G Ho-Yen D. Control of ticks on humans. Eds Hendry G Ho-Yen D . In Ticks. A lay guide to a human hazard. Edinburgh, Mercat Press, 1998, 1st edition, 66–76.

Dennis DT Hayes EB Orloski KA Meltzer MI. Recommendations for the use of Lyme disease vaccine. MMWR 1999; 48: 1–25.

Thanassi WT Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000; 132: 661–668.

Hsia EC Chung JB Schwartz JS Albert DA. Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis Rheum 2002; 46: 1651–1660.

Luft BJ Dunn JJ Lawson CL. Approaches towards the directed design of a vaccine against Borrelia burgdorferi . J Infect Dis, 2002; 185 (suppl 1): S46–S51.

www2.lymenet.org/domino/file.nsf/uid/guidelines.

www.fairfieldweekly.com/articles/lymedisease.html.

www.niaid.nih.gov/publications/ticks.htm.

Rowe PM. Chronic Lyme disease: the debate goes on. Lancet 2000; 355: 1436.

Klempner MS Hu LT Evans J Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345: 85–92.

Patel R Grogg KL Edwards WD Wright AJ Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis 2000; 31: 1107–1109.

Molloy PJ Persing DH Berardi VP. False positive results of PCR testing for Lyme disease. Clin Infect Dis 2001; 33: 412–413.

Hul§nsk D VotΩpka J Valesov M. Persìstence of Borrelia garinii and Borrelia afzelii in patients with Lyme arthritis. Zent bl Bakteriol 1999; 289: 301–318.

Limbach F-X Jaulhac B Puechal X Treatment resistant Lyme arthritis caused by Borrelia garinii. Ann Rheum Dis 2000; 60: 284–286.

Burkert S Rssler D Mnchhof F P Wilske B. Development of enzyme-linked immunosorbent assays using recombinant borrelial antigens for serodiagnosis of Borrelia burgdorferi infection. Med Microbiol Immunol 1996; 185: 49–57.

Kaiser R Rauer S. Advantage of recombinant borrelial proteins for serodiagnosis of neuroborreliosis. J Med Microbiol 1999; 48: 5–10.

Magnarelli LA Fikrig E Padula SJ Anderson JF Flavell RA. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol 1996; 34: 237–240.

Lawrenz MB Hardham JM Owens RT Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferí . J Clin Microbiol 1999; 37: 3997–4004.

Brunner M Stein S Mitchell PD Sigal LH. Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope. J Clin Microbiol 1998; 36: 1074–1080.

Brunner M Sigal LH. Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi . J Clin Microbiol 2001; 39: 3213–3221.

Burgdorfer W. Arthropod-borne spirochetoses: a historical perspective. Eur J Clin Microbiol Infect Dis 2001; 20: 1–5.

Phillips SE Mattman LH Hulinska D Moayad H. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infection 1998; 26: 348–367.

Nowakowski J Schwartz I Liveris D Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001; 33: 2023–2027.

Curtin SM Pennington TH. Borrelia burgdorferi studies in man and ticks in Scotland. Eds. Axford JS Rees DHE . In: Lyme Borreliosis New York, Plenum Press 1994: 147–154.